Trends in hepatitis A seroprevalence may impact on the production of effective immunoglobulin products for passive immunisation. The seroprevalence of hepatitis A antibodies in blood donors in capital cities around Australia was measured using a commercial ELISA. Hepatitis A antibodies were quantified using...
Impact of the national targeted hepatitis A immunisation program in Australia: 2000–2014. Vaccine 35, 170–176 (2017). Article PubMed Google Scholar Aggarwal, R. & Goel, A. Hepatitis A: epidemiology in resource-poor countries. Curr. Opin. Infect. Dis. 28, 488–496 (2015). Article CAS...
Impact of the national targeted hepatitis A immunisation program in Australia: 2000–2014. Vaccine 35, 170–176 (2017). Article PubMed Google Scholar Aggarwal, R. & Goel, A. Hepatitis A: epidemiology in resource-poor countries. Curr. Opin. Infect. Dis. 28, 488–496 (2015). Article CAS...
E Wiseman,MA Fraser,S Holden - 《Medical Journal of Australia》 被引量: 0发表: 2009年 Targeted hepatitis B vaccination--a cost effective immunisation strategy for the UK? Objective - To compare the potential cost effectiveness of vaccination against hepatitis B virus (HBV) targeted at genitourina...
immunisation has a great impact on the prevalence o Hepatitis B in whole population. Compared with unvaccinated persons, vaccinated persons have lower HBsAg and anti-HBc prevalences. Additionally, the logistic regression analysis highlights the signi cant actor – ...
Viral hepatitis continues to merit the rank of ‘greatest importance’ among the unconquered diseases of mankind. The general term, viral hepatitis, refers principally to hepatitis A (infectious hepatitis) and to hepatitis B (serum hepatitis), although..
1. A fully synthetic vaccine for the prophylaxis of B-hepatitis has been developed and used in man, and 2. the use of passive and active immunisation with hepatitis-B vaccines has been examined. In particular, immunisation of newborns of mothers with B-hepatitis has been assessed. Additional ...
Immunisation with gamma globulin to Murray Valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against Aus... In northwestern Australia, the flavivirus Murray Valley encephalitis (MVE) poses a significant health risk to infants in some aboriginal communities...
A medical librarian refined the search strategy. Detailed search records for each database are shown in Supplementary material 1. Study screening After removing duplicates using Covidence (Veritas Health Innovation, Melbourne, Australia), four researchers independently screened the titles and abstracts of ...
The history of modern research on viral hepatitis began in the year 1963, when Nobel Prize winner Baruch S. Blumberg (1925–2011) reported for the first time publicly on the discovery of a new antigen named Australia antigen (AuAg) (reference [1], page 82). In the years following, AuAg...